?Cancer Research Career Enhancement The Mays Cancer Center (MCC) Cancer Research Career Enhancement (CRCE) Core seeks to provide a continuous supply of well-trained cancer scientists performing state-of-the-art cancer research. The Core is led by Robin Leach, Ph.D., (PSP) Associate Director (AD) for Education and a member of the Cancer Center since its inception. The UT Health San Antonio (UT Health SA) is the largest academic Health Science Center for South Texas and includes Schools of Medicine, Nursing, Dentistry, Health Professions, and the Graduate School of Biomedical Sciences. The UT Health SA is designated by the U.S. Department of Education as a Hispanic- serving Institution and consistently ranks as one of the top schools in the U.S. for graduating Hispanic health care providers. The MCC at the UT Health SA places a high priority on education and mentoring, and does so both within the Cancer Center and by integrating and coordinating activities with existing programs at UT Health SA. The MCC has dedicated resources to cancer-related training and career development from high schoolers through early- stage faculty levels. During the last reporting period, the MCC has provided cancer research training for 51 high school students and 155 undergraduates in summer enrichment and training programs. MCC members have trained 115 M.S. and 147 Ph.D. level graduate students, 30 medical students (via an accredited medical school research electives course), 25 M.D./Ph.D. students, and 2 D.D.S./Ph.D. students. A total of 70 physicians have completed MCC?s fellowships in Hematology and Medical Oncology, Advanced Oncology Drug Development, Urologic Oncology and Pediatric Hematology-Oncology. In new activities, the CRCE Core has established an Office of Education at the MCC, revitalized an advisory MCC Education Committee, and established an Affiliate membership category for trainees. Importantly, the CRCE Core has augmented cancer-related research mentoring for early-stage faculty who are Associate Members of MCC, partnering the basic scientists with senior clinical faculty and the clinical scientists with senior basic science faculty. During the upcoming funding period, the Core will continue summer training in cancer research for high school through college students, and develop new training opportunities for middle school students. Importantly, most of these efforts will target opportunities for underrepresented populations. We will also leverage and expand the existing cancer-related education and training activities throughout UT Health SA. We will continue to support mentoring and career development among advanced trainees ? from fellows through early-stage faculty ? with an emphasis on fostering participation of underserved minorities to produce a more diverse cancer research workforce of the future.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA054174-25
Application #
10025086
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-08-01
Project End
2025-07-31
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
25
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Texas Health Science Center
Department
Type
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Yu, Xiaojie; Zhang, Yiqiang; Ma, Xiuye et al. (2018) miR-195 potentiates the efficacy of microtubule-targeting agents in non-small cell lung cancer. Cancer Lett 427:85-93
Ankerst, Donna P; Goros, Martin; Tomlins, Scott A et al. (2018) Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk Calculator. Eur Urol Focus :
Arora, Sukeshi Patel; Mahalingam, Devalingam (2018) Immunotherapy in colorectal cancer: for the select few or all? J Gastrointest Oncol 9:170-179
Arellano, Luisa M; Arora, Sukeshi Patel (2018) Systemic Treatment of Advanced Hepatocellular Carcinoma in Older Adults. J Nat Sci 4:
Du, Liqin; Zhao, Zhenze; Suraokar, Milind et al. (2018) LMO1 functions as an oncogene by regulating TTK expression and correlates with neuroendocrine differentiation of lung cancer. Oncotarget 9:29601-29618
Ankerst, Donna P; Straubinger, Johanna; Selig, Katharina et al. (2018) A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts. Eur Urol 74:197-203
Sun, Xiujie; Gupta, Kshama; Wu, Bogang et al. (2018) Tumor-extrinsic discoidin domain receptor 1 promotes mammary tumor growth by regulating adipose stromal interleukin 6 production in mice. J Biol Chem 293:2841-2849
Horning, Aaron M; Wang, Yao; Lin, Che-Kuang et al. (2018) Single-Cell RNA-seq Reveals a Subpopulation of Prostate Cancer Cells with Enhanced Cell-Cycle-Related Transcription and Attenuated Androgen Response. Cancer Res 78:853-864
Gong, Siqi; Tomusange, Khamis; Kulkarni, Viraj et al. (2018) Anti-HIV IgM protects against mucosal SHIV transmission. AIDS 32:F5-F13
Gelfond, Jonathan; Goros, Martin; Hernandez, Brian et al. (2018) A System for an Accountable Data Analysis Process in R. R J 10:6-21

Showing the most recent 10 out of 989 publications